Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 46 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: marrow stromal cells Clear all

Conditions: Chronic Pancreatitis, Mesenchymal Stem Cells
Interventions: Bone marrow-derived mesenchymal stem cells, Placebo; Biological · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Secondary Progressive Multiple Sclerosis (SPMS)
Interventions: NG01 - Autologous bone marrow derived human stromal cells, Sodium Chloride 0.9%; Biological · Other
Lead sponsor: NeuroGenesis Ltd.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Bone Disease, Craniofacial Abnormality, Healthy
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1994 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Xerostomia Following Radiotherapy
Interventions: Autologous bone-marrow derived, interferon gamma stimulated mesenchymal stromal cells; Biological
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Corneal Ulcer
Interventions: Mesenchymal Stromal Cells, Control Solution; Biological · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 4
States / cities: Chicago, Illinois • Baltimore, Maryland • Boston, Massachusetts + 1 more

Conditions: Kidney Tubular Necrosis, Acute
Interventions: Multipotent Stromal Cells, Administration of MSC; Biological
Lead sponsor: AlloCure Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Murray, Utah • Salt Lake City, Utah

Conditions: Chronic Pancreatitis, Diabetes
Interventions: autologous mesenchymal stromal cell; Biological
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 69 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: System; Lupus Erythematosus
Interventions: Low Dose Mesenchymal Stem Cells (MSCs); Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Atlanta, Georgia • Charleston, South Carolina

Conditions: Heart Disease, Ischemic Heart Disease, Coronary Artery Disease, Coronary Artery Disease (CAD)
Interventions: Cell Therapy; Other
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Cardiomyopathy, Heart Failure
Interventions: Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell Transplantation; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Crohn's Disease
Interventions: autologous mesenchymal stromal cell; Biological
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Congenital Heart Disease (CHD)
Interventions: BM-MSC; Biological
Lead sponsor: Catherine Bollard; Other
Eligibility: Up to 6 Months
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Inflammatory Bowel Diseases
Interventions: Allogeneic bone marrow-derived mesenchymal stromal cells; Biological
Lead sponsor: Catherine Bollard; Other
Eligibility: 12 Years to 22 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease, Vascular Disease, Arterial Occlusive Disease, Arteriosclerosis, Atherosclerosis, Cardiovascular Disease, Pathologic Processes, Orthopedic Procedures, Amputation
Interventions: Allogeneic bone marrow derived mesenchymal stem cells; Biological
Lead sponsor: Indiana University; Other
Eligibility: 40 Years to 90 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Respiratory Distress Syndrome, Adult
Interventions: Human Mesenchymal Stromal Cells, Cell Reconstitution Media; Biological
Lead sponsor: Michael A. Matthay; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 7
States / cities: Sacramento, California • San Francisco, California • Portland, Oregon + 3 more

Conditions: Sickle Cell Disease, Thalassemia, Diamond-Blackfan Anemia
Interventions: Bone marrow transplantation, Mesenchymal Stromal Cells; Procedure · Biological
Lead sponsor: Stanford University; Other
Eligibility: 1 Year to 25 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Birmingham, Alabama • Minneapolis, Minnesota

Conditions: Kidney Transplantation, Renal Transplantation, Renal Transplant Recipient
Interventions: Donor-derived Mesenchymal Stromal Cells, alemtuzumab, belatacept, sirolimus, mycophenolate mofetil, mycophenolate acid, prednisone; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 19 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteoporosis
Interventions: Stromal Cells Sample; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Sars-CoV2, Acute Respiratory Distress Syndrome, COVID-19
Interventions: Mesenchymal Stromal Cells, Supportive Care; Biological · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Graft-Versus-Host Disease
Interventions: MSC; Biological
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 4 Years to 99 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Acetabular Labrum Tear, Femoro Acetabular Impingement, Chondral Defect, Bone Marrow Aspirate Concentrate, Mesenchymal Stromal Cell
Interventions: BMAC; Biological
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteogenesis Imperfecta Type II, Osteogenesis Imperfecta Type III
Interventions: Mesenchymal Stromal Cells; Biological
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: Up to 19 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Polyostotic Fibrous Dysplasia
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 4 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Xerostomia, Head and Neck Cancer
Interventions: Bone Marrow Aspiration, Ultrasound Imaging of Salivary Glands, Salivary Assay, Quality of Life Instruments; Procedure · Diagnostic Test · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 89 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis

Bone Regeneration Using Bone Marrow Stromal Cells

MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery

Mesenchymal Stem Cell and Islet Co-transplantation

Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.

Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)

Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease

A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation

Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome

Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs

Tolerance by Engaging Antigen During Cellular Homeostasis

Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation

Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)

Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids

Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear

Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta

Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome

Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia